Amarin Corp Plc (AMRN)

[Shinook99]

I only disagree with your peak sales estimate. If they get a full label >135 then why wouldn’t peak sales be closer to Lipitor at 13B.

Essentially everyone needing Lipitor would also be the target market for V. Then you factor in all the other possible indications on the horizon...I won’t consider those for now.

But on Lipitor’s peak alone 13B * 5 = 65B —- $170ish SP

Assume they hit half of Lipitor’s peak — 6ishB ... 6+B * 5 = 30B —— $85 SP